Related Experiment Video
Updated: May 28, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
HIV-1 Protease: Structural Perspectives on Drug Resistance
Irene T Weber1, Johnson Agniswamy
1Department of Biology, Molecular Basis of Disease Program, Georgia State University, Atlanta, GA 30303, USA;
Viruses
|October 14, 2011
Summary
Structure-based drug design has yielded successful HIV-1 protease inhibitors, improving AIDS therapy. Analyzing drug-resistant variants reveals resistance mechanisms, guiding the development of new antiviral drugs for HIV.
Area of Science:
- Biochemistry
- Drug Discovery
- Virology
Background:
- Antiviral inhibitors targeting HIV-1 protease represent a significant advancement in AIDS therapy.
- Structure-based drug design has been instrumental in developing these effective treatments.
Purpose of the Study:
- To analyze the molecular mechanisms of drug resistance in HIV-1 protease variants.
- To guide the design of novel inhibitors effective against resistant HIV strains.
Main Methods:
- Structural analysis of drug-resistant HIV-1 protease variants.
- Activity assays to assess inhibitor efficacy and resistance profiles.
- Computational modeling to understand resistance mechanisms.
Main Results:
- Identified distinct molecular mechanisms of drug resistance, including altered protease-inhibitor/substrate interactions, changes in dimer stability, and distal mutations affecting the active site.
- Revealed how specific mutations confer resistance to existing antiviral drugs.
Conclusions:
- Understanding resistance mechanisms is crucial for overcoming treatment challenges in HIV/AIDS.
- These insights will drive the development of next-generation antiviral inhibitors targeting resistant HIV strains.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...